NasdaqCM - Delayed Quote USD

Scilex Holding Company (SCLX)

5.42 +0.14 (+2.56%)

At close: September 4 at 4:00:00 PM EDT

5.42 0.00 (0.00%)

After hours: September 4 at 7:30:02 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.

CNW Group 15d ago

SCLX
+2.56%
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted

Zacks Small Cap Research 9mo ago

SCLX
+2.56%
ORMP

DRTS
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

GlobeNewswire 3mo ago

SCLX
+2.56%
SMNR
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

GlobeNewswire 2mo ago

SCLX
+2.56%
Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)

InvestorsHub 1mo ago

SCLX
+2.56%
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited

GlobeNewswire 3mo ago

SCLX
+2.56%
PHOE
Wade Defendants Dispute Complaint and Statement by Scilex Holding Company

CNW Group 3mo ago

SCLX
+2.56%
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

GlobeNewswire 1mo ago

SCLX
+2.56%
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

PR Newswire 7mo ago

SCLX
+2.56%
ORMP
Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

GlobeNewswire 2mo ago

SCLX
+2.56%
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

GlobeNewswire 1mo ago

SCLX
+2.56%
SMNRW
Scilex, Vera Therapeutics rise premarket; Strategy gains

Investing.com 1mo ago

VERA

SCLX
+2.56%
^DJI

Performance Overview

Return	SCLX	S&P 500 (^GSPC)
YTD	-28.72%	+12.75%
1-Year	-57.33%	+18.71%
3-Year	-91.98%	+70.93%

Yahoo Finance

U.S. markets closed

Scilex Holding Company (SCLX)

Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.

ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)

Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited

Wade Defendants Dispute Complaint and Statement by Scilex Holding Company

Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

Scilex, Vera Therapeutics rise premarket; Strategy gains

Performance Overview